Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-26

Clinical Trial Update: Renal Denervation in Patients With Uncontrolled Hypertension - SYMPLICITY HTN-4 [NA]

View source ↗

Summary

Clinical trial update indicating the SYMPLICITY HTN-4 study evaluating renal denervation for uncontrolled hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Medtronic Vascular | Conditions: Hypertension, Vascular Diseases | NA | Status: COMPLETED